Percutaneous transhepatic portal embolization using foam ethanolamine oleate and carbon dioxide (CO2): a clinical study
Project/Area Number |
25861111
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Radiation science
|
Research Institution | Kumamoto University |
Principal Investigator |
|
Research Collaborator |
YAMASHITA Yasuyuki
KAWANAKA Koichi
IKEDA Osamu
BEPPU Toru
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
Fiscal Year 2015: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2014: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | 経皮経肝的門脈塞栓術 / 泡沫化硬化剤 / オルダミン / 泡沫硬化剤 |
Outline of Final Research Achievements |
Percutaneous transhepatic portal embolization (PTPE) can induce atrophy of the embolized- and hypertrophy of the residual area. These effects are advantageous in patients scheduled for extended hepatectomy. To evaluate the experimental clinical safety and effectiveness of foam sclerotherapy with foam ethanolamine oleate (EO) and carbon dioxide (CO2) for PTPE. Sclerotherapy using foam EOI and CO2 is clinically safe and effective for PTPE before hepatectomy.
|
Report
(4 results)
Research Products
(1 results)